Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study

BACKGROUND: Vaccine-induced immunity is essential for controlling the COVID-19 pandemic. Data on humoral and cellular immunogenicity and safety of different SARS-CoV-2 vaccines in patients with autoimmune rheumatic and musculoskeletal diseases (RMDs) are limited. METHODS: A single center observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Szebeni, Gábor J., Gémes, Nikolett, Honfi, Dániel, Szabó, Enikő, Neuperger, Patrícia, Balog, József Á., Nagy, Lajos I., Szekanecz, Zoltán, Puskás, László G., Toldi, Gergely, Balog, Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008200/
https://www.ncbi.nlm.nih.gov/pubmed/35432314
http://dx.doi.org/10.3389/fimmu.2022.846248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008200/
https://www.ncbi.nlm.nih.gov/pubmed/35432314
http://dx.doi.org/10.3389/fimmu.2022.846248

Ejemplares similares